Ligand Pharmaceuticals

NASDAQ: LGND · Real-Time Price · USD
150.89
-2.90 (-1.89%)
At close: Aug 15, 2025, 3:59 PM
151.08
0.13%
After-hours: Aug 15, 2025, 04:10 PM EDT

Ligand Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-4.03M 52.15M -33.36M 57.14M
Depreciation & Amortization
37.85M 35.64M 51.37M 50.95M
Stock-Based Compensation
41.09M 25.74M 60.28M 38.78M
Other Working Capital
2.29M -16.23M 1.64M -21.95M
Other Non-Cash Items
18.58M -41.26M -26.84M -7.29M
Deferred Income Tax
-15.8M 11.7M 20.72M -8.62M
Change in Working Capital
19.36M -34.4M 65.68M -52.16M
Operating Cash Flow
97.05M 49.58M 137.85M 78.8M
Capital Expenditures
-1.82M -3.52M -17.92M -8.76M
Cash Acquisitions
-92M -10.4M -750K 494K
Purchase of Investments
-200.6M -142.01M -51.23M -181.32M
Sales Maturities Of Investments
262.5M 194.17M 234.39M 221.34M
Other Investing Acitivies
-111.75M -49.91M -868K -1.22M
Investing Cash Flow
-143.66M -11.68M 163.62M 30.52M
Debt Repayment
-25K -76.9M -261M -146.01M
Common Stock Repurchased
-5.14M -4.55M -8.24M -18.45M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
60.45M 16.95M -6.75M 8.25M
Financial Cash Flow
97.57M -59.95M -275.99M -137.76M
Net Cash Flow
49.35M -22.05M 25.48M -28.44M
Free Cash Flow
95.23M -4.27M 119.93M 70.04M